Lars Christian Wilde

The Otto Wilde history kicked off in 2015 after Otto, Alex, Julia, and Nils jointly formed the plan to bring new impulse to the grilling market. Innovation took form with the O.F.B. which was realized thanks to grill enthusiasts via Kickstarter. This used Otto Wilde as a starting point to perpetually reinvent themselves and set new standards for grilling fans regarding experience and taste. The delivery of the O.F.B. was not the only milestone at Otto Wilde. Earning several design awards showed how much Otto Wilde values grilling. They ventured in new terrains with the G32, an outdoor kitchen, which was launched as a Kickstarter project and came out phenomenally successful. Since April 2021, Otto Wilde was happy to announce that they joined Miele in future endeavors and additionally opened an own flagship store on Düsseldorf’s “Kö”. Currently 50 employees put their combined efforts in Otto Wilde’s vision which has not changed much from its early days. Setting high quality standards in grilling experience or taste and sharing them with an enthusiast community is still the top priority. Grilling is still a big passion at Otto Wilde according to the motto: Meat ain’t no Firlefanz.

Opening up a world of opportunity for our customers, investors, ourselves and the planet. Were a financial services organisation that serves more than 40 million customers, ranging from individual savers and investors to some of the world’s biggest companies and governments. Our network covers 63 countries and territories, and we’re here to use our unique expertise, capabilities, breadth and perspectives to open up a world of opportunity for our customers. HSBC is listed on the London, Hong Kong, New York, and Bermuda stock exchanges. To view our social media terms and conditions please visit the following webpage: http://www.hsbc.com/social-TandCs

We combine computational metabolomics, knowledge graph reasoning, and machine learning to decode plant chemistry at scale, identifying novel, patent-protectable health ingredients at a fraction of traditional cost and time. Our mission is to bring a new generation of evidence-based natural compounds to market, shifting health from reactive treatment to proactive wellbeing.

We are a clinical stage company developing novel therapeutics inspired by kanna, or Sceletium tortuosum. Kanna is a medicinal succulent traditionally used by the San hunter-gatherers of South Africa.

Pangea Bio is developing novel therapies that directly activate the TrkB receptor, driving neuronal and synaptic plasticity, and neuroprotection. Dysfunction of the BDNF/TrkB pathway is a hallmark of disorders such as schizophrenia, depression, Alzheimer’s disease, Parkinson’s disease, and glaucoma.

We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first clinical development programme is researching investigational COMP360 psilocybin treatment for patients with treatment-resistant depression. We want to transform the patient experience in mental health care.

AtaiBeckley is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting and convenient mental health treatments.